Page last updated: 2024-09-02

1-hydroxymethylmidazolam and norfluoxetine

1-hydroxymethylmidazolam has been researched along with norfluoxetine in 1 studies

Compound Research Comparison

Studies
(1-hydroxymethylmidazolam)
Trials
(1-hydroxymethylmidazolam)
Recent Studies (post-2010)
(1-hydroxymethylmidazolam)
Studies
(norfluoxetine)
Trials
(norfluoxetine)
Recent Studies (post-2010) (norfluoxetine)
16346492753369

Protein Interaction Comparison

ProteinTaxonomy1-hydroxymethylmidazolam (IC50)norfluoxetine (IC50)
Potassium channel subfamily K member 2Homo sapiens (human)9
Sodium channel protein type 1 subunit alphaRattus norvegicus (Norway rat)0.8
Potassium voltage-gated channel subfamily C member 1Rattus norvegicus (Norway rat)0.8
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)2.2909

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Binkley, SN; Ring, BJ; Roskos, L; Wrighton, SA1

Other Studies

1 other study(ies) available for 1-hydroxymethylmidazolam and norfluoxetine

ArticleYear
Effect of fluoxetine, norfluoxetine, sertraline and desmethyl sertraline on human CYP3A catalyzed 1'-hydroxy midazolam formation in vitro.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 275, Issue:3

    Topics: 1-Naphthylamine; Catalysis; Cytochrome P-450 CYP2E1; Cytochrome P-450 Enzyme System; Fluoxetine; Humans; Microsomes, Liver; Midazolam; Mixed Function Oxygenases; Selective Serotonin Reuptake Inhibitors; Sertraline

1995